ANTIBODY-DRUG CONJUGATES COMPRISING ANTI-B7-H3 ANTIBODIES

The present disclosure relates to antibody-drug conjugates (ADCs) wherein one or more active agents are conjugated to an anti-B7-H3 antibody through a linker. The linker may comprise a unit that covalently links active agents to the antibody. The disclosure further relates to monoclonal antibodies a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Song, Jina, Song, Youngja, Shim, Eun-Young, Jung, Doohwan, Lee, Minju, Lee, Hyang Sook, Kim, Sunyoung, Lee, Hyun Mi, Park, Taekyo, Park, Suho, Park, Okku, Lee, Jaeho, Seol, Minah, Ha, Jihyeon, Seo, Beomseok, Seo, Donghoon, Lee, Eunjin, Park, Jae Eun, Cho, Jongun, Park, Young Woo, Ko, Yunjung, Yun, Sanghyeon, Woo, Sung Ho, Kim, Sena, Lee, Hyun Ju, Lee, Sangkwang, Rew, Yosup
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure relates to antibody-drug conjugates (ADCs) wherein one or more active agents are conjugated to an anti-B7-H3 antibody through a linker. The linker may comprise a unit that covalently links active agents to the antibody. The disclosure further relates to monoclonal antibodies and antigen binding fragments, variants, multimeric versions, or bispecifics thereof that specifically bind B7-H3, as well as methods of making and using these anti-B7-H3 antibodies and antigen-binding fragments thereof in a variety of therapeutic, diagnostic and prophylactic indications.